Biovail
Canadian pharmaceutical company / From Wikipedia, the free encyclopedia
Biovail Corporation was a Canadian pharmaceutical company, operating internationally in all aspects of pharmaceutical products. Its major production facility was located in Steinbach, Manitoba. It merged with Valeant Pharmaceuticals International in 2010.
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
TSX: BVF | |
Industry | Biotechnology Pharmaceutical |
Founded | 1991 |
Founder | Eugene Melnyk Rolf Reininghaus Mahmood Khan |
Defunct | 2010 (2010) |
Fate | Merged with Valeant Pharmaceuticals International |
Headquarters | Mississauga, Ontario, Canada |
Area served | North America |
Key people | Dr. Douglas J.P. Squires (Chairman of the Board) William M. Wells (CEO) |
Products | Medicine Drugs |
Revenue | $ 757.18 million (2008) |
$ 114.24 million (2008) | |
$ 199.90 million (2008) | |
Total assets | $ 1.623 billion (2008) |
Total equity | $ 1.201 billion (2008) |
Number of employees | 1,368 - March 2009 |
Divisions | Biovail Pharmaceuticals Canada (BPC) Biovail Contract Research (Canada) Biovail Corporation (Canada) |
Subsidiaries | Biovail Pharmaceuticals, Inc. (BPI) (U.S.) Biovail Technologies Ltd. (U.S.) Biovail Laboratories - Dorado (Puerto Rico) Biovail Laboratories - Carolina (Puerto Rico) Biovail Laboratories International SRL (Barbados) Biovail Technologies (Ireland) Limited |
Website | www.biovail.com |
Close